Common eCOA Implementation Mistakes That Delay Study Startup

And best practices that keep your timeline on track

By Jenn Allsbrook, Vice President, Customer Success

Study startup decisions made months before first patient in (FPI) can make or break an eCOA implementation timeline. Small missteps in communication, protocol readiness, licensing, and language planning can compound quickly, turning a scheduled study launch into a moving target. Knowing where eCOA studies typically go off track, and building the right guardrails from day one, is what separates a build that stays on schedule from one that slips.

Common Sticking Points That Delay Study Startup

While every study is different, several common issues show up again and again in eCOA builds:

• Changing requirements after build starts. Ethics committees (ECs), Institutional Review Boards (IRBs), and regulators frequently send protocols back requesting additional information, a different scale, or a revised assessment frequency. When build starts against a preliminary draft protocol, teams work at risk, and any resulting change can force a significant reassessment of the eCOA build and questionnaire logic, pushing timelines out.
• Planning to go live in a language other than English. Because eCOA is patient-facing, content must be built and tested in a regulatory-approved language before FPI. Teams that plan a non-English FPI but treat translation as parallel work, rather than a dependency on finalized English screens, routinely underestimate how much lead time translation and linguistic validation actually require.
• Underestimating licensing and copyright approvals. Securing rights to a licensed scale, along with any edits the license holder requires, can take longer than expected. Whether linguistic validation is required for a given language is frequently up to the copyright holder, which makes this a critical-path item rather than background work.
• Adding or reprioritizing study design features late in the build. Changing agreed study design requirements after build is underway can result in additional translation, programming, and testing cycles that were never built into the original timeline.
• Underestimating device logistics. For studies using provisioned devices, coordination of procurement, configuration, shipping, and country-specific import requirements are critical path considerations. Timeline considerations compound if devices are also needed for UAT in a non-English language.

Best Practices to Keep Study Startup on Track

The good news is that each of these risks can be managed with careful planning and strong communication.

• Set up strong, open communication from day one. Agree on communication channels, meeting cadence, and points of contact before build starts, and make sure everyone understands what can change a timeline and how. Surfacing questions and potential issues the moment they arise, rather than waiting for them to compound, keeps small items from becoming late-stage delays.
• Identify and track key milestones together. Protocol finalization, submission dates, UAT, FPI, and subsequent language rollout should be planned at the onset and tracked regularly with the eCOA vendor. Dates change, so a frequent meeting cadence that asks whether milestones are still aligned makes it possible to catch slippage early and drive risk mitigation before it affects the build and delivery timelines.
• Confirm protocol stability before build starts. Stable, agreed questionnaires, licensed scales, and a settled schedule of assessments are what protect a build from rework. A good eCOA partner works with sponsors early to identify which protocol elements are firm and which may still evolve, so build can proceed with a clear view of risk.
• Get ahead of licensing, translation, and linguistic validation. Identify early which languages and countries need to move first, and confirm licensing and linguistic validation requirements with the copyright holder before they become a bottleneck.
• Plan device logistics as its own workstream. Identify early on which devices are needed, in what quantities, in which countries, and what shipping and import requirements apply, including for UAT.

How uMotif Helps Ensure a Successful eCOA Study Launch

uMotif builds successful eCOA study launches centered on communication, responsiveness, and continuous learning. Our approach starts with a transparent operational framework covering who we communicate with across an organization, how we communicate through KPIs, dashboards, and shared design standards, what we track through defined milestones like build time and UAT timelines, and when those conversations happen, typically weekly at the project level.

When questions or issues come up, our Customer Success team is empowered to respond quickly and accurately, assembling a core internal team, keeping clients updated, and aligning across a client’s full study portfolio when needed. And after every study, we capture what worked well and reuse questionnaire modules, app functionality, and translations where it makes sense, an approach that has helped cut time to launch by more than 30% for some clients.

That same discipline shapes how we run UAT, with regular check-ins, an open help line, and a cross-functional response team so testing stays productive and on track for go-live. And because licensing and translation offer some of the biggest opportunities to save time, uMotif’s Scientific Consulting Services provide dedicated support for COA licensing management alongside broader study design and regulatory guidance, helping sponsors move forward with confidence from day one.

For clients with higher study or portfolio volume, that same weekly project-level cadence extends to monthly or quarterly governance-level reviews, giving sponsors a broader view of trends and opportunities across their full program.

The studies that launch on schedule are the ones built with a partner who plans ahead, communicates constantly, and brings a governance model designed to keep momentum going from day one.

Q&A

What is the biggest cause of eCOA study startup delays?

Changes to study requirements after build has started, most often triggered by EC, IRB, or regulatory feedback on a draft protocol, are the most common driver. When the protocol isn’t stable, build and questionnaire logic often need to be reassessed, which pushes timelines out.

How early should licensing and translation be addressed in an eCOA build?

As early as possible. Licensing and copyright approvals for scales, along with linguistic validation requirements, should be confirmed before build starts, and language and country rollout should be sequenced up front so translation isn’t a late-stage scramble.

What should sponsors look for in an eCOA vendor to avoid delays?

Look for a vendor with a clear governance model for communication and milestone tracking, a disciplined approach to UAT, and dedicated scientific support for licensing and study design, since these are the areas most likely to introduce risk to a timeline.